55 research outputs found
Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma â a study of the United Kingdom Children's Cancer Study Group
The administration of 13-cis-retinoic acid (13-cisRA), following myeloablative therapy improves 3-year event-free survival rates in children with high-risk neuroblastoma. This study aimed to determine the degree of inter-patient pharmacokinetic variation and extent of metabolism in children treated with 13-cisRA. 13-cis-retinoic acid (80âmgâmâ2 b.d.) was administered orally and plasma concentrations of parent drug and metabolites determined on days 1 and 14 of courses 2, 4 and 6 of treatment. Twenty-eight children were studied. The pharmacokinetics of 13-cisRA were best described by a modified one-compartment, zero-order absorption model combined with lag time. Mean population pharmacokinetic parameters included an apparent clearance of 15.9âlâhâ1, apparent volume of distribution of 85âl and absorption lag time of 40âmin with a large inter-individual variability associated with all parameters (coefficients of variation greater than 50%). Day 1 peak 13-cisRA levels and exposure (AUC) were correlated with method of administration (P<0.02), with 2.44- and 1.95-fold higher parameter values respectively, when 13-cisRA capsules were swallowed as opposed to being opened and the contents mixed with food before administration. Extensive accumulation of 4-oxo-13-cisRA occurred during each course of treatment with plasma concentrations (mean±s.d. 4.67±3.17âÎŒM) higher than those of 13-cisRA (2.83±1.44âÎŒM) in 16 out of 23 patients on day 14 of course 2. Extensive metabolism to 4-oxo-13-cisRA may influence pharmacological activity of 13-cisRA
Suppression in Pb-Pb Collisions at the LHC.
The production of the Ï(2S) charmonium state was measured with ALICE in Pb-Pb collisions at sqrt[s_{NN}]=5.02ââTeV, in the dimuon decay channel. A significant signal was observed for the first time at LHC energies down to zero transverse momentum, at forward rapidity (2.5<y<4). The measurement of the ratio of the inclusive production cross sections of the Ï(2S) and J/Ï resonances is reported as a function of the centrality of the collisions and of transverse momentum, in the region p_{T}<12ââGeV/c. The results are compared with the corresponding measurements in pp collisions, by forming the double ratio [Ï^{Ï(2S)}/Ï^{J/Ï}]_{Pb-Pb}/[Ï^{Ï(2S)}/Ï^{J/Ï}]_{pp}. It is found that in Pb-Pb collisions the Ï(2S) is suppressed by a factor of âŒ2 with respect to the J/Ï. The Ï(2S) nuclear modification factor R_{AA} was also obtained as a function of both centrality and p_{T}. The results show that the Ï(2S) resonance yield is strongly suppressed in Pb-Pb collisions, by a factor of up to âŒ3 with respect to pp. Comparisons of cross section ratios with previous Super Proton Synchrotron findings by the NA50 experiment and of R_{AA} with higher-p_{T} results at LHC energy are also reported. These results and the corresponding comparisons with calculations of transport and statistical models address questions on the presence and properties of charmonium states in the quark-gluon plasma formed in nuclear collisions at the LHC
- âŠ